ES534695A0 - Un procedimiento para preparar ester 1-acetoxietilico de cefuroxima cristalino, muy puro - Google Patents

Un procedimiento para preparar ester 1-acetoxietilico de cefuroxima cristalino, muy puro

Info

Publication number
ES534695A0
ES534695A0 ES534695A ES534695A ES534695A0 ES 534695 A0 ES534695 A0 ES 534695A0 ES 534695 A ES534695 A ES 534695A ES 534695 A ES534695 A ES 534695A ES 534695 A0 ES534695 A0 ES 534695A0
Authority
ES
Spain
Prior art keywords
cefuroxyme
acetoxyethylene
ester
prepare
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES534695A
Other languages
English (en)
Spanish (es)
Other versions
ES8601869A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES8601869A1 publication Critical patent/ES8601869A1/es
Publication of ES534695A0 publication Critical patent/ES534695A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES534695A 1983-07-29 1984-07-27 Un procedimiento para preparar ester 1-acetoxietilico de cefuroxima cristalino, muy puro Granted ES534695A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838320521A GB8320521D0 (en) 1983-07-29 1983-07-29 Chemical process

Publications (2)

Publication Number Publication Date
ES8601869A1 ES8601869A1 (es) 1985-11-01
ES534695A0 true ES534695A0 (es) 1985-11-01

Family

ID=10546505

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534695A Granted ES534695A0 (es) 1983-07-29 1984-07-27 Un procedimiento para preparar ester 1-acetoxietilico de cefuroxima cristalino, muy puro

Country Status (21)

Country Link
JP (1) JPH0613526B2 (de)
KR (1) KR910008377B1 (de)
AT (1) AT392470B (de)
AU (2) AU582121B2 (de)
BE (1) BE900241A (de)
CA (1) CA1265511A (de)
CH (1) CH662121A5 (de)
DE (1) DE3427828A1 (de)
DK (1) DK165505C (de)
ES (1) ES534695A0 (de)
FI (1) FI76808C (de)
FR (1) FR2549837B1 (de)
GB (2) GB8320521D0 (de)
IE (1) IE57726B1 (de)
IL (1) IL72536A (de)
NL (1) NL8402372A (de)
NO (1) NO167292C (de)
NZ (1) NZ209046A (de)
PT (1) PT78985B (de)
SE (1) SE463263B (de)
ZA (1) ZA845830B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
IT1277426B1 (it) * 1995-08-03 1997-11-10 Acs Dobfar Spa Forma cristallina biodisponibile del cefuroxima axetil
CN1111537C (zh) * 1997-05-15 2003-06-18 第一制糖株式会社 高纯晶形头孢呋辛1-乙酰氧乙酯的制备方法
KR100228264B1 (ko) * 1997-08-02 1999-11-01 김선진 결정형 세푸록심 악세틸의 제조방법
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
IN186539B (de) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
EP0937727B1 (de) * 1998-02-20 2002-01-30 Fako Ilaclari A.S. Verfahren zur Herstellung vom löslichen kristallinen Cefuroxim axetil
IN190849B (de) 2000-07-17 2003-08-23 Ranbaxy Lab Ltd
AT411996B (de) 2000-09-11 2004-08-26 Sandoz Ag Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes
ITMI20011763A1 (it) * 2001-08-10 2003-02-10 Antibioticos Spa Processo di preparazione di cefuroxime axelite ad elevata purezza
ITMI20011925A1 (it) * 2001-09-14 2003-03-14 Antibioticos Spa Metodo applicabile su scala industriale per la preparazione di cefuroxime axetile cristallino
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
CN100448879C (zh) * 2004-07-22 2009-01-07 北京化工大学 一种无定型头孢呋辛酯的制备方法
DE102005019458A1 (de) * 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
CN118561870A (zh) * 2024-05-15 2024-08-30 广东立国制药有限公司 一种制备头孢呋辛酸的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
JPS577485A (en) * 1980-06-13 1982-01-14 Takeda Chem Ind Ltd Cephalosporin
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics

Also Published As

Publication number Publication date
DK165505B (da) 1992-12-07
FR2549837B1 (fr) 1986-12-26
ATA244484A (de) 1990-09-15
JPS6075484A (ja) 1985-04-27
SE8403897L (sv) 1985-01-30
IL72536A (en) 1988-01-31
FI76808B (fi) 1988-08-31
DE3427828A1 (de) 1985-02-14
FI843011L (fi) 1985-01-30
FI843011A0 (fi) 1984-07-27
NZ209046A (en) 1988-02-29
PT78985B (en) 1986-10-23
NL8402372A (nl) 1985-02-18
KR910008377B1 (ko) 1991-10-12
ES8601869A1 (es) 1985-11-01
KR850001221A (ko) 1985-03-16
NO843055L (no) 1985-01-30
AU582121B2 (en) 1989-03-16
CH662121A5 (de) 1987-09-15
DK366684D0 (da) 1984-07-27
PT78985A (en) 1984-08-01
FR2549837A1 (fr) 1985-02-01
AT392470B (de) 1991-04-10
FI76808C (fi) 1988-12-12
GB2145409A (en) 1985-03-27
SE463263B (sv) 1990-10-29
AU3660189A (en) 1989-10-05
AU3125684A (en) 1985-01-31
GB2145409B (en) 1987-02-18
NO167292B (no) 1991-07-15
GB8419202D0 (en) 1984-08-30
SE8403897D0 (sv) 1984-07-27
BE900241A (fr) 1985-01-28
IL72536A0 (en) 1984-11-30
NO167292C (no) 1991-10-23
DK366684A (da) 1985-01-30
IE841938L (en) 1985-01-29
IE57726B1 (en) 1993-03-24
GB8320521D0 (en) 1983-09-01
DK165505C (da) 1993-04-19
JPH0613526B2 (ja) 1994-02-23
ZA845830B (en) 1986-03-26
CA1265511A (en) 1990-02-06
AU634965B2 (en) 1993-03-11

Similar Documents

Publication Publication Date Title
ES534695A0 (es) Un procedimiento para preparar ester 1-acetoxietilico de cefuroxima cristalino, muy puro
ES544852A0 (es) Un procedimiento para la preparacion de derivados sustituidos ester benzoato de 3-hidroximorfinanos.
ES554044A0 (es) Procedimiento para preparar un derivado de ciclohexano hidroxibromado
ES548672A0 (es) Un procedimiento para la preparacion de un derivado de dihi-dropiridina
ES545756A0 (es) Un procedimiento para la preparacion de un derivado de acido6-fluor-1,4-dihidro-4-oxo-7-piperazinilquinolin sustituido-3-carboxilico
FR2574135B1 (fr) Cheville a expansion par cone
ES533474A0 (es) Procedimiento para modificar un elemento quirurgico estructural
ES540003A0 (es) Un procedimiento para preparar un derivado de octahidrobenzo(f) quinoleina
ES543646A0 (es) Un procedimiento para la preparacion de derivados esteroida-les
ES534509A0 (es) Un procedimiento para la preparacion de acidos fenilquinolin-carboxilicos.
ES532859A0 (es) Un procedimiento para producir fenilalanina
ES534607A0 (es) Un procedimiento para la preparacion de un derivado de poliol-eter.
ES535981A0 (es) Un procedimiento para la preparacion de derivados de benzofurano
ES522597A0 (es) Un procedimiento para la produccion de diesteres de acidos sulfosuccinicos
ES541505A0 (es) Un procedimiento para la preparacion de monohidrato de bis- hidrobromuro de ceftazidima cristalino
DE3482255D1 (de) Kristallines silicophosphoaluminat.
ES531343A0 (es) Un procedimiento para producir zincosilicatos cristalinos porosos
DK606384D0 (da) Fremgangsmaade til fremstilling af krystallinske silicophosphoaluminater
ES527237A0 (es) Un procedimiento para producir derivados de tiazol
ES540839A0 (es) Un procedimiento para producir un derivado de ester de cefa-losporina
ES523288A0 (es) Procedimiento para preparar un derivado de pirazolpiridina.
ES535392A0 (es) Un procedimiento para la preparacion de derivados de imidazobenzodiacepina
ES546645A0 (es) Procedimiento para preparar un pseudooligosacarido
ES531498A0 (es) Un procedimiento para la preparacion de derivados de pirimidinatriona
ES534252A0 (es) Procedimiento de preparar un dentifrico antiplacas, estable